[12] Angela M. Davies, Uri Weinberg, and Yoram Palti. Tumor treating ?elds: a new frontier in cancer therapy. New York Academy of Sciences. 1291 (2013) 86–95. doi: 10.1111/nyas.12112
[13] Stupp, R., Wong, E. T., Kanner, A. A., et al. NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality. European Journal of Cancer.48:14 (2012),2192–2202. doi:10.1016/j.ejca.2012.04.011
[14] Wolfgang Wick. TTFields: where does all the skepticism come from? Neuro-Oncology.18:3(2016), 303–305. doi:10.1093/neuonc/now012
[15] Toms, S. A., Kim, C. Y., Nicholas, G., & Ram, Z. Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial. Journal of Neuro-Oncology.141:2(2018),467–473. doi:10.1007/s11060-018-03057-z
- 有癌症,易房颤!韩国82万例患者研究
- 心衰治疗里程碑突破!首个miRNA药物证明安全有效!
- 深圳科学家提出肿瘤精准治疗新思路
- 淋巴瘤患者的福音!苏州大学探寻新的治疗靶点
- 晚期癌症只能活活痛死?癌症根本不用治?肿瘤科医生讲了四个真相
- 【医伴旅】200mg剂量的非戈替尼治疗中重度溃疡性结肠炎安全有效
- 癌症会一代传一代?父母若得了5种癌,子女可能会“继承”
- 医万个为什么 | 康焱:关节严重变形,为什么手术是唯一治疗方法?
- EULAR重磅更新:GRAPPA发布PsA治疗最新建议!IL-17抑制剂获一线推荐!
- 医疗|长期染发会致癌吗?提醒:一种染发剂与癌症相关,学会4个技巧